Cannabis Using Schizophrenia Patients Treated with Atypical Neuroleptics: Do Their Symptoms Differ from Those of Cannabis Abstainers?

References

• Anderson , L. A. , Anderson , J. J. , Chase , T. N. and Walters , J. R. 1995 . The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway . Brain Research , 691 : 106 – 114 .
   PubMed Web of Science ®Google Scholar
• Arndt , S. , Tyrrell , G. , Flaum , M. and Andreasen , N. C. 1992 . Comorbidity of substance abuse and schizophrenia: The role of pre-morbid adjustment . Psychological. Medicine , 22 : 379 – 388 .
   PubMed Web of Science ®Google Scholar
• Baigent , M. , Holme , G. and Hafner , R. J. 1995 . Abstract self-reports of the interaction between substance abuse and schizophrenia . Australian and New Zealand Journal of Psychiatry , 29 : 69 – 74 .
   PubMed Web of Science ®Google Scholar
• Buckley , P. , Thompson , P. , Way , L. and Meltzer , H. Y. 1994 . Substance abuse among patients with treatment-resistant schizophrenia: Characteristics and implications for clozapine therapy . American Journal of Psychiatry , 151 : 385 – 389 .
   PubMed Web of Science ®Google Scholar
• Cantor-Graae , E. , Nordstrom , L. G. and McNeil , T. F. 2001 . Substance abuse in schizophrenia: A review of the literature and a study of correlates in Sweden . Schizophrenia Research , 48 : 69 – 82 .
   PubMed Web of Science ®Google Scholar
• Compton , M. T. , Furman , A. C. and Kaslow , N. J. 2004 . Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: Preliminary evidence from an African American first-episode sample . Schizophrenia Research , 71 : 61 – 64 .
   PubMed Web of Science ®Google Scholar
• Dervaux , A. , Laqueille , X. , Bourdel , M. C. , Leborgne , M. H. , Olie , J. P. , Loo , H. and Krebs , M. O. 2003 . Cannabis and schizophrenia: Demographic and clinical correlates . Encephale , 29 : 11 – 17 .
   PubMed Web of Science ®Google Scholar
• Dixon , L. , Haas , G. , Weiden , P. J. , Sweeney , J. and Frances , A. J. 1991 . Drug abuse in schizophrenic patients: Clinical correlates and reasons for use . American Journal of Psychiatry , 148 : 224 – 230 .
   PubMed Web of Science ®Google Scholar
• Drake , R. E. , Xie , H. , McHugo , G. J. and Green , A. I. 2000 . The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia . Schizophrenia Bulletin , 26 : 441 – 449 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Burgess , E. S. , Dawson , R. , Zimmet , S. V. and Strous , R. D. 2003 . Alcohol and cannabis use in schizophrenia: Effects of clozapine vs. risperidone . Schizophrenia Research , 60 : 81 – 85 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Tohen , M. F. , Hamer , R. M. , Strakowski , S. M. , Lieberman , J. A. , Glick , I. , Clark , W. S. and HGDH Research Group . 2004 . First-episode schizophrenia-related psychosis and substance use disorders: Acute response to olanzapine and haloperidol . Schizophrenia Research , 66 : 125 – 135 .
   PubMed Web of Science ®Google Scholar
• Jablensky , A. , Sartorius , N. , Ernberg , G. , Anker , M. , Korten , A. , Cooper , J. E. , Day , R. and Bertelsen , A. 1992 . Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organization ten-country study . Psychological Medicine, Monograph Supplement , 20 : 1 – 97 .
   PubMedGoogle Scholar
• Joyal , C. C. , Halle , P. , Lapierre , D. and Hodgins , S. 2003 . Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia . Schizophrenia Research , 63 : 297 – 299 .
   PubMed Web of Science ®Google Scholar
• Kapur , S. , Zipursky , R. B. , Remington , G. , Jones , C. , DaSilva , J. , Wilson , A. A. and Houle , S . 1998 . 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation . American Journal of Psychiatry , 155 : 921 – 928 .
   PubMed Web of Science ®Google Scholar
• Kay , S. R. , Fiszbein , A. and Opler , L. A. 1987 . The positive and negative syndrome scale (PANSS) for schizophrenia . Schizophrenia Bulletin , 13 : 261 – 276 .
   PubMed Web of Science ®Google Scholar
• Kessler , R. C. , Birnbaum , H. , Demler , O. , Falloon , I. R. , Gagnon , E. , Guyer , M. , Howes , M. J. , Kendler , K. S. , Shi , L. , Walters , E. and Wu , E. Q. 2005 . The prevalence and correlates of nonaffective psychosis in the national comorbidity survey replication (NCS-R) . Biological Psychiatry , 58 : 668 – 676 .
   PubMed Web of Science ®Google Scholar
• Lee , M. A. and Meltzer , H. Y. 2001 . “ Substance abuse in schizophrenia. Biological factors mediating comorbidity and the potential role of atypical antipsychotic drugs ” . In Substance abuse in the mentally and physically disabled , Edited by: Hubbard , J. R. and Martin , P. R. 77 – 101 . New York : Marcel Dekker .
   Google Scholar
• Linszen , D. H. , Dingemans , P. M. and Lenior , M. E. 1994 . Cannabis abuse and the course of recent-onset schizophrenic disorders . Archives of General Psychiatry , 51 : 273 – 279 .
   PubMed Web of Science ®Google Scholar
• Lysaker , P. , Bell , M. , Beam-Goulet , J. and Milstein , R. 1994 . Relationship of positive and negative symptoms to cocaine abuse in schizophrenia . Journal of Nervous and Mental Disease , 182 : 109 – 112 .
   PubMed Web of Science ®Google Scholar
• Marchese , G. , Casti , P. , Ruiu , S. , Saba , P. , Sanna , A. , Casu , G. and Pani , L. 2003 . Haloperidol, but not clozapine, produces dramatic catalepsy in Delta9-THC-treated rats: Possible clinical implications . British Journal of Pharmacology , 140 : 520 – 526 .
   PubMed Web of Science ®Google Scholar
• Martinez-Arevalo , M. J. , Calcedo-Ordonez , A. and Varo-Prieto , J. R. 1994 . Cannabis consumption as a prognostic factor in schizophrenia . British Journal of Psychiatry , 164 : 679 – 681 .
   PubMed Web of Science ®Google Scholar
• Noordsy , D. L. and Green , A. I. 2003 . Pharmacotherapy for schizophrenia and co-occurring substance use disorders . Current Psychiatry Reports , 5 : 340 – 346 .
   PubMedGoogle Scholar
• Scheller-Gilkey , G. , Thomas , S. M. , Woolwine , B. J. and Miller , A. H. 2002 . Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia . Schizophrenia Bulletin , 28 : 223 – 231 .
   PubMed Web of Science ®Google Scholar
• Sundram , S. , Copolov , D. and Dean , B. 2005 . Clozapine decreases [(3)H] CP 55940 binding to the cannabinoid-(1)-receptor in the rat nucleus accumbens . Naunyn Schmiedebergs Archives Pharmacology , 371 : 428 – 433 .
   PubMed Web of Science ®Google Scholar